Group One Trading Portfolio holdings
AUM
$3.05B
1-Year Return
3.54%
This Quarter Return
+1.77%
1 Year Return
+3.54%
3 Year Return
+10.97%
5 Year Return
+15.65%
10 Year Return
+24.6%
AUM
$3.18B
AUM Growth
+$663M
(+26%)
Cap. Flow
+$391M
Cap. Flow
% of AUM
12.3%
Top 10 Holdings %
Top 10 Hldgs %
23.39%
Holding
3,672
New
501
Increased
548
Reduced
584
Closed
538
Top Buys
| 1 |
NVIDIA
NVDA
|
+$101M |
| 2 |
Advanced Micro Devices
AMD
|
+$77.3M |
| 3 |
Tesla
TSLA
|
+$61.3M |
| 4 |
Microsoft
MSFT
|
+$40.1M |
| 5 |
First Solar
FSLR
|
+$29.1M |
Top Sells
| 1 |
Albemarle
ALB
|
+$37.9M |
| 2 |
JPMorgan Chase
JPM
|
+$23.9M |
| 3 |
Walt Disney
DIS
|
+$16M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$15.7M |
| 5 |
Coinbase
COIN
|
+$14.4M |
Sector Composition
| 1 | Technology | 27.85% |
| 2 | Consumer Discretionary | 12.93% |
| 3 | Healthcare | 12.6% |
| 4 | Financials | 10.8% |
| 5 | Communication Services | 8.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1201
Acacia Research
ACTG
$304M
| $26.8K | ﹤0.01% |
6,837
-182
| -3% | -$713 |
|
1202
INmune Bio
INMB
$52.4M
| $26.7K | ﹤0.01% |
2,375
-43,614
| -95% | -$491K |
|
1203
AudioEye
AEYE
$160M
| $26.5K | ﹤0.01% |
4,898
+4,322
| +750% | +$23.4K |
|
1204
Braze
BRZE
$3.44B
| $26.5K | ﹤0.01% |
+498
| New | +$26.5K |
|
1205
Alliant Energy
LNT
$16.4B
| $26.4K | ﹤0.01% |
+515
| New | +$26.4K |
|
1206
Lazard
LAZ
$5.25B
| $26.4K | ﹤0.01% |
758
-517
| -41% | -$18K |
|
1207
Karyopharm Therapeutics
KPTI
$53.8M
| $26.4K | ﹤0.01% |
2,032
-1,602
| -44% | -$20.8K |
|
1208
Manitowoc
MTW
$357M
| $26.4K | ﹤0.01% |
1,579
+546
| +53% | +$9.11K |
|
1209
OR Royalties Inc.
OR
$6.69B
| $26.2K | ﹤0.01% |
+1,838
| New | +$26.2K |
|
1210
Equity Residential
EQR
$25.5B
| $26.2K | ﹤0.01% |
+429
| New | +$26.2K |
|
1211
Alliance Resource Partners
ARLP
$2.89B
| $26.1K | ﹤0.01% |
+1,233
| New | +$26.1K |
|
1212
NorthWestern Energy
NWE
$3.47B
| $26K | ﹤0.01% |
+510
| New | +$26K |
|
1213
Renaissance IPO ETF
IPO
$186M
| $25.8K | ﹤0.01% |
685
+300
| +78% | +$11.3K |
|
1214
Carisma Therapeutics
CARM
$15.8M
| $25.8K | ﹤0.01% |
8,790
+178
| +2% | +$522 |
|
1215
Actinium Pharmaceuticals
ATNM
$50.2M
| $25.6K | ﹤0.01% |
+5,040
| New | +$25.6K |
|
|
ZH
1216
Zhihu
ZH
$450M
| $25.3K | ﹤0.01% |
4,495
-2,000
| -31% | -$11.2K |
|
1217
Spruce Power Holding Corp
SPRU
$28.7M
| $24.9K | ﹤0.01% |
5,639
+637
| +13% | +$2.82K |
|
|
FAZE
1218
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
| $24.7K | ﹤0.01% |
137,145
+200
| +0.1% | +$36 |
|
1219
Supernus Pharmaceuticals
SUPN
$2.59B
| $24.7K | ﹤0.01% |
+852
| New | +$24.7K |
|
1220
Lexicon Pharmaceuticals
LXRX
$403M
| $24.6K | ﹤0.01% |
+16,054
| New | +$24.6K |
|
1221
SS&C Technologies
SSNC
$21.6B
| $24.4K | ﹤0.01% |
+400
| New | +$24.4K |
|
1222
Organogenesis Holdings
ORGO
$617M
| $24.4K | ﹤0.01% |
5,955
-4,811
| -45% | -$19.7K |
|
1223
ESS Tech
GWH
$20.5M
| $24.3K | ﹤0.01% |
1,421
+1,073
| +308% | +$18.4K |
|
1224
Precigen
PGEN
$1.23B
| $24.2K | ﹤0.01% |
18,096
-3,451
| -16% | -$4.62K |
|
1225
Sabesp
SBS
$15.8B
| $24.2K | ﹤0.01% |
1,590
+851
| +115% | +$13K |
|